Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4860539
Max Phase: Preclinical
Molecular Formula: C15H16N2O6
Molecular Weight: 320.30
Molecule Type: Unknown
Associated Items:
ID: ALA4860539
Max Phase: Preclinical
Molecular Formula: C15H16N2O6
Molecular Weight: 320.30
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(O)c1ccc2nc(CO[C@@H]3C=CO[C@H](CO)[C@@H]3O)[nH]c2c1
Standard InChI: InChI=1S/C15H16N2O6/c18-6-12-14(19)11(3-4-22-12)23-7-13-16-9-2-1-8(15(20)21)5-10(9)17-13/h1-5,11-12,14,18-19H,6-7H2,(H,16,17)(H,20,21)/t11-,12-,14-/m1/s1
Standard InChI Key: KHQQXFVNQRTING-YRGRVCCFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 320.30 | Molecular Weight (Monoisotopic): 320.1008 | AlogP: 0.41 | #Rotatable Bonds: 5 |
Polar Surface Area: 124.90 | Molecular Species: ACID | HBA: 6 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 2.96 | CX Basic pKa: 4.96 | CX LogP: -1.49 | CX LogD: -3.52 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.63 | Np Likeness Score: 0.39 |
1. Hassan M, Baussière F, Guzelj S, Sundin AP, Håkansson M, Kovačič R, Leffler H, Tomašič T, Anderluh M, Jakopin Ž, Nilsson UJ.. (2021) Structure-Guided Design of d-Galactal Derivatives with High Affinity and Selectivity for the Galectin-8 N-Terminal Domain., 12 (11.0): [PMID:34795863] [10.1021/acsmedchemlett.1c00371] |
Source(1):